biote Corp. (BTMD): Cash & Equivalents

Annual figures by period end, from SEC filings.

$24.12M
As of 2025-12-31
$11.17M
As of 2026-06-30
-32.7%
3-year compound annual growth
n/m
5-year compound annual growth
$89.00M2020-12-31: $1.6K2021-12-31: $130.4K2022-12-31: $79.23M2023-12-31: $89.00M2024-12-31: $39.34M2025-12-31: $24.12M$24.12M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$24.12M-38.7%2026-03-13, Balance as of period end
2024-12-31$39.34M-55.8%2026-03-13, Balance as of period end
2023-12-31$89.00M+12.3%2025-03-14, Balance as of period end
2022-12-31$79.23Mn/m2024-03-15, Balance as of period end
2021-12-31$130.4Kn/m2022-04-07, Balance as of period end
2020-12-31$1.6Kn/a2022-04-07, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
biote Corp. (BTMD)2025-12-31$24.12M-38.7%
Marimed Inc. (MRMD)2024-12-31$7.28M-50.3%
Cronos Group Inc. (CRON)2025-12-31$791.79M-7.8%
Natural Alternatives International Inc (NAII)2026-06-30$7.39M-40.1%
Jushi Holdings Inc. (JUSH)2025-12-31$24.05M+23.2%
Niagen Bioscience, Inc. (NAGE)2024-12-31$44.50M+63.6%
Mannatech Inc (MTEX)2025-12-31$6.18M-45.7%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$85.68M-2.9%
Cresco Labs Inc. (CRLBF)2025-12-31$57.90M-57.9%

Compare BTMD, MRMD, CRON, NAII side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗